Skip to main content
. 2021 Jan 12;7:593976. doi: 10.3389/fmolb.2020.593976

Table 1.

Clinical characteristics of subjects.

Variables HC (n = 29) neCRSwNP (n = 33) eCRSwNP (n = 37) P-value
Age (years), mean ± SD 28.5 ± 8.5 32.8 ± 12.2 35.1 ± 14.8 0.103
Gender (male/female), n 14/15 18/15 19/18 0.885
Smoking (yes/no), n 10/19 17/16 19/18 0.306
Drinking (yes/no), n 7/22 8/25 12/25 0.673
BMI (kg/m2), mean ± SD 22.2 ± 1.8 22.7 ± 1.8 22.3 ± 1.5 0.570
B-EOS counts (106/L), mean ± SD 81.2 ± 24.0 174.7 ± 84.4 405.8 ± 159.3 <0.001
B-EOS percentage, % 1.2 ± 0.8 2.2 ± 1.0 4.5 ± 1.2 <0.001
VAS score, mean ± SD 5.5 ± 1.5 5.9 ± 1.7 0.300
Lund-Mackay score, mean ± SD 18.8 ± 3.9 18.2 ± 3.8 0.499

eCRSwNP, eosinophilic chronic rhinosinusitis with nasal polyps; neCRSwNP, non-eosinophilic chronic rhinosinusitis with nasal polyps; HC, healthy control; SD, standard deviation; BMI, body mass index; B-EOS, blood eosinophil; VAS, visual analog scale.